AI can help design AI systems: automating architecture choices, discovering algorithms, and optimizing hardware ...
Opinion
Modern Engineering Marvels on MSNOpinion

AI’s self‑improvement crossroads: The 2030 AGI risk window

Toward the end of this decade, a choice may face the species that could reshape its interactions with intelligence itself and this choice is whether or not it shall allow highly advanced AI systems to ...
The free software community has always thwarted the toughest challenges facing freedom in technology. This winter season, we want to thank the many individuals and projects that have helped us get ...
The surge of AI has, for an array of users, complicated tasks such as fixing a blocked bank account, reporting fraud or ...
Precise underwater navigation is critical for autonomous and remotely operated deep-sea vehicles, yet variations in seawater ...
Nvidia's restraint — focusing on enabling the ecosystem rather than owning it — has helped cement its role as the ...
AI use in Kurdistan is surging, aiding youth employment and trade, but experts warn of privacy risks and future self-teaching systems matching human capabilities.
Getting good at LeetCode Java isn’t just about solving problems; it’s about having a good plan. You need to know where to ...
The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...
Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...